EWG Elevate’s Lam Research LRCX Stock Holding History

EWG Elevate’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-150	Closed	-$6.3K	–	457
2022 Q4	$6.3K	Buy	+150	New	+$6.28K	﹤0.01%	439

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EWG Elevate's LRCX Position: Q1 2023 in Review

EWG Elevate sold out of Lam Research (LRCX) in Q1 2023, closing a stake of 150 shares — an estimated $6.3K sold.

EWG Elevate first reported a position in LRCX in Q4 2022 and held it in 1 quarter. The position peaked at $6.3K in Q4 2022. 1,363 funds tracked by Wall St. Rank hold LRCX as of Q1 2023.

EWG Elevate reported no remaining Lam Research position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 150 Lam Research shares in Q1 2023, an estimated $6.3K.
EWG Elevate first reported a position in Lam Research in Q4 2022 and held it in 1 quarter.
EWG Elevate's Lam Research position peaked at $6.3K in Q4 2022.
1,363 funds tracked by Wall St. Rank held Lam Research as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.